1. Brunel University Research Archive
  2. College of Health, Medicine and Life Sciences
  3. Dept of Life Sciences
  4. Dept of Life Sciences Research Papers
Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/29417
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAloj, L-
dc.contributor.authorAttili, B-
dc.contributor.authorLau, D-
dc.contributor.authorCaraco, C-
dc.contributor.authorLechermann, LM-
dc.contributor.authorMendichovszky, IA-
dc.contributor.authorHarper, I-
dc.contributor.authorCheow, H-
dc.contributor.authorCasey, RT-
dc.contributor.authorSala, E-
dc.contributor.authorGilbert, FJ-
dc.contributor.authorGallagher, FA-
dc.date.accessioned2024-07-26T07:22:51Z-
dc.date.available2024-07-26T07:22:51Z-
dc.date.issued2020-06-12-
dc.identifierORCiD: Luigi Aloj https://orcid.org/0000-0002-7452-4961-
dc.identifierORCiD: Ai Hui Doreen Lau https://orcid.org/0000-0002-7623-2401-
dc.identifierORCiD: Laura Lechermann https://orcid.org/0000-0002-2742-6269-
dc.identifierORCiD: Evis Sala https://orcid.org/0000-0002-5518-9360-
dc.identifierORCiD: Fiona Gilbert https://orcid.org/0000-0002-0124-9962-
dc.identifierORCiD: Ferdia Gallagher https://orcid.org/0000-0003-4784-5230-
dc.identifier.citationAloj, L. et al. (2021) 'The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy', Nuclear Medicine and Biology, 92, pp. 53 - 64. doi: 10.1016/j.nucmedbio.2020.06.005.en_US
dc.identifier.issn0969-8051-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/29417-
dc.description.abstractTargeting specific cell membrane markers for both diagnostic imaging and radionuclide therapy is a rapidly evolving field in cancer research. Some of these applications have now found a role in routine clinical practice and have been shown to have a significant impact on patient management. Several molecular targets are being investigated in ongoing clinical trials and show promise for future implementation. Advancements in molecular biology have facilitated the identification of new cancer-specific targets for radiopharmaceutical development.en_US
dc.description.sponsorshipThis work was supported by Cancer Research UK, the CRUK Cambridge Centre, the CRUK & Engineering and Physical Science Research Council (EPSRC) Cancer Imaging Centre in Cambridge and Manchester, the Mark Foundation for Cancer Research, Addenbrooke's Charitable Trust, the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre, Cambridge Experimental Cancer Medicine Centre, CRUK National Cancer Imaging Translational Accelerator (NCITA).en_US
dc.format.extent53 - 64-
dc.format.mediumPrint-Electronic-
dc.languageEnglish-
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.rightsCopyright © 2020 Elsevier. All rights reserved. This manuscript version is made available under the Creative Commons (CC-BY-NC-ND 4.0) Attribution-NonCommercial-NoDerivatives 4.0 International license (https://creativecommons.org/licenses/by-nc-nd/4.0/), see: https://www.elsevier.com/about/policies/sharing.-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectreceptorsen_US
dc.subjectcell membrane proteinsen_US
dc.subjectpositron emission tomographyen_US
dc.subjecttargeted radionuclide therapyen_US
dc.subjectradiopharmaceutical developmenten_US
dc.titleThe emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapyen_US
dc.typeArticleen_US
dc.date.dateAccepted2020-06-10-
dc.identifier.doihttps://doi.org/10.1016/j.nucmedbio.2020.06.005-
dc.relation.isPartOfNuclear Medicine and Biology-
pubs.publication-statusPublished-
pubs.volume92-
dc.identifier.eissn1872-9614-
dc.rights.holderElsevier-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2020 Elsevier. All rights reserved. This manuscript version is made available under the Creative Commons (CC-BY-NC-ND 4.0) Attribution-NonCommercial-NoDerivatives 4.0 International license (https://creativecommons.org/licenses/by-nc-nd/4.0/), see: https://www.elsevier.com/about/policies/sharing.768.21 kBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons